Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Environmental Science & Technology|November 30, 2007
Mesoporous nitrogen-doped TiO2 for the photocatalytic destruction of the cyanobacterial toxin microcystin-LR under visible light irradiationHyeok Choi, Maria G Antoniou, Miguel Pelaez, et al.
The Science of the Total Environment|April 16, 2013
Required ozone doses for removing pharmaceuticals from wastewater effluentsMaria G Antoniou, Gerly Hey, Sergio Rodríguez Vega, et al.
Musculoskeletal Surgery|February 8, 2020
Total hip arthroplasty and sexual activity: a systematic reviewE M Neonakis, F Perna, F Traina, et al.
In Vivo (Athens, Greece)|September 13, 2002
Cell proliferation and DNA fragmentation (apoptosis) on FNABs of breast invasive ductal carcinomas and their relationship to clinicopathological variables and prognosisA M Kalogeraki, Ch G Antoniou, J P Askoxylakis, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 29, 2011
Can we effectively degrade microcystins?--Implications on human healthArmah A de la Cruz, Maria G Antoniou, Anastasia Hiskia, et al.
Journal of Environmental Management|August 22, 2025
Pilot-scale production of high-purity struvite fertilizer from livestock waste: Outcomes of the RE-LIVE WASTE project in CyprusNomiki I Kallikazarou, Olympia Nisiforou, Despoina A Kokkinidou, et al.
Environmental Science. Processes & Impacts|September 24, 2013
A review on cylindrospermopsin: the global occurrence, detection, toxicity and degradation of a potent cyanotoxinArmah A de la Cruz, Anastasia Hiskia, Triantafyllos Kaloudis, et al.
Contraception|April 28, 2005
Effect of oral contraceptive treatment on bone mass acquisition in skeletally immature young female ratsMakarios I Eleftheriades, Irene V Lambrinoudaki, George E Christodoulakos, et al.
Frontiers in Oncology|July 15, 2022
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and TemozolomideDaniela A Bota, Thomas H Taylor, Naomi Lomeli, et al.
Marine Drugs|March 4, 2016
A Collaborative Evaluation of LC-MS/MS Based Methods for BMAA Analysis: Soluble Bound BMAA Found to Be an Important FractionElisabeth J Faassen, Maria G Antoniou, Wendy Beekman-Lukassen, et al.
Pageof 9